1/9
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Reagent regulations
how is blood regulated
what certifies reagents
regulation criterias
Blood regulated like drug by FDA
CBER certifies reagents → establish minimum criteria
Package insert (instructions)
Intention + how it is made + testing info
Facility policies
Reagent QC done on day of use
Polyclonal vs monoclonal Abs vs blended
Polyclonal: mixture of IgM and IgG Abs made by B cell clones to detect multiple epitopes on Ag
Monoclonal: hybridomas derived from myeloma cells to target specific epitope w/ IgM OR IgG
Blended: diversity (either monoclonal or poly + mono)
overcomes disadvantages of over specificity of monoclonal
ABO antigen typing
forward grouping
use of monoclonal IgM
D antigen typing
high vs low protein
Reagent control
when to use
ABO antigen typing
forward grouping: looking for Ag
determine ABO phenotype of pt cells (use anti-A and anti-B + agglutination)
monoclonal IgM helps detect weak A and B Ag expression
D antigen typing
High protein = historical- not used anymore
Low protein = monoclonal or mono/poly blends
IgM Abs = immediate spin
IgG Abs = weak D testing
Reagent control
high-protein reagents
A, B, and D testing all positive
Reagent RBCs
what is it?
types and use
Known Ag for detecting unknown Ab
A1 and B cells:
used for reverse grouping: looking for Ab → confirms forward testing
Screening cells:
detects non-ABO Abs
Panel cells
wider range of cells to specify Ab detected
Antihuman globulin
purpose
examples
DAT vs IAT
AHG control cells types
bridges gap bc IgG too tiny for agglutination
anti-IgG, anti-C3d, polyspecific AHG (both), monospecific AHG (seperate)
DAT: in vivo; 1 step (cells alr sensitized)
IAT: in vitro; 2 steps (incubate for sensitization)
AHG control cells:
IgG coated or C3 coated group O cells
confirm neg rxns
Potentiators
what is it
what does it do
what types + what they do + effect
“Enhancement media”
looks for IgG in IAT
low-ionic strength solution (LISS)
reduces electrostatic charge around RBC = better Ab uptake + agglutination
Polyethylene glycol (PEG)
removes water molecules → RBC get closer + concentrates Ab enhancing uptake
Bodine albumin
allow Ab sensitized cells to come together = better agglutination
Enzymes
proteolytic?
destroys what
enhances what
common enzymes
Proteolytic: removes neg charges and glycoprotein fragments from RBC
Destroyed by enzymes: duffy, MNS
“Enhanced” by enzymes: ABO, Rh, Lewis, Kidd, H, I, Lutheran
Common enzymes:
Ficin- from figs
Papain- from papauas
Bromelain- from pineapples
Lectins
what?
types?
Alternate to antisera → cause agglutination
Types
Dolicho biflorus: anti-A1 lectin
Ulex europaeus: anti-H lectin
Sources of errors in agglutination
false pos
false neg
False positive | False negative |
Dirty glassware | Delayed testing → not adding AHG immediately |
agglutinated RBC present before washing then added AGH | Failed to wash before adding AHG |
Over centrifugation | Failed to ID weak pos rxn |
No adding AHG | |
Loss of reagent activity | |
Under centrifugation | |
Inappropriate RBC concentration → RBC suspension fall outside optimal 2-5% |
Are the following IAT or DAT?
Drug-related mechanisms (IgG–drug complex on RBC)
Antibody screening (detect atypical non-ABO antibodies before transfusion)
IgG and/or C3 bound to patient RBCs
Abs produced by passenger lymphocytes (donor B cells attack recipient RBCs)
Weak D test (detects presence of D antigen)
Passively acquired alloantibodies (transfused or infused antibodies)
Nonspecifically absorbed proteins (globulins coating RBCs)
Crossmatch (tests serologic compatibility)
Donor or fetal cells sensitized with IgG antibodies
Antigen typing
Activation of complement (C3 binds RBCs and is detected by AHG reagent)
Antibody identification (determines antibody specificity in patient or donor)
DAT
IAT
DAT
DAT
IAT
DAT
DAT
IAT
DAT
IAT
DAT
IAT